There are currently 80 active clinical trials seeking participants for Diabetes research studies. The states with the highest number of trials for Diabetes participants are California, Texas, Florida and Pennsylvania.
Addressing Diabetes by Elevating Access to Nutrition
NCT05228860
Recruiting
The goal of ADELANTE is to determine whether a multi-level intervention to improve household food insecurity and glycemic control is effective for Latino patients with diabetes. Specifically, ADELANTE aims to determine whether weekly household food delivery plus an intensive lifestyle intervention is more effective than usual care for improving glycemic control (HbA1c) at 6 months, examine the effects of the multi-level intervention on = household food insecurity, dietary behaviors, and psycho... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/28/2023
Locations: La Clínica Monument, Concord, California
Conditions: Diabetes, Obesity, Lifestyle, Healthy
Register for Updates
Assessing Open Access Audio
NCT04452331
Recruiting
The medical encounter can be overwhelming in term of the amount of information discussed, its technical nature, and the anxiety it can generate. Easy access to a secure audio recording from any internet enabled device is an available low cost technology that allows patients to "revisit the visit" either alone or sharing with caretakers and family. It has been introduced and tested outside the VA with evidence that it increases patient recall and understanding and may even improve physician perfo... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/19/2023
Locations: Jesse Brown VA Medical Center, Chicago, IL, Chicago, Illinois +1 locations
Conditions: Hypertension, Diabetes
Register for Updates
Diabetes Clinical Decision Support
NCT05447806
Recruiting
The purpose of this study is to determine the impact of an electronic medical record clinical decision support tool on rates of dysglycemia in the hospital, and its clinical and economical outcomes. The study also evaluates the perspectives of providers regarding the tool's usefulness on disease management support, knowledge, and practice performance.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/12/2023
Locations: Milton S. Hershey Medical Center, Hershey, Pennsylvania +1 locations
Conditions: Hyperglycemia, Hyperglycemia Stress, Diabetes, PreDiabetes, Hypoglycemia
Register for Updates
Effect of SGLT2i on Cardiovascular Biomarkers in Patients With Type 2 Diabetes and CKD Stage 3b-4
NCT05033054
Recruiting
This is a prospective, observational study to assess the effect of SGLT2 inhibitors on surrogate markers of kidney and cardiovascular health in patients with stage 3b and 4 chronic kidney disease (CKD). This study includes three clinic in person visits and weekly telephone visits for 12 weeks. Recruit 28 patients with CKD stages 3b-4 and follow up for 12 weeks Determine the effect of interventions on the primary outcome variable serum klotho measured by immunoprecipitation-immunoblot
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
08/29/2023
Locations: UT Southwestern Medical Center, Dallas, Texas
Conditions: Kidney Disease, Chronic, Diabetes
Register for Updates
Food Assistance, Diabetes, and HIV
NCT04045184
Recruiting
Diabetes prevalence is increasing among people living with HIV (PLWH), yet blood glucose control is less successful in this population who are also often food insecure. Food assistance programs often provide nutrient-poor foods. This proposal asses the feasibility of monitoring diabetes-related health outcomes among food insecure PLWH who are receiving food boxes higher in dietary protein and fiber and lower in simple carbohydrates.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/28/2023
Locations: UAB, Birmingham, Alabama
Conditions: Diabetes, HIV/AIDS, FOOD SECURITY
Register for Updates
Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation
NCT04207619
Recruiting
Hypoglycemic complications are a major impediment to the maintenance of healthy glucose levels in persons with diabetes. The investigators recently completed a clinical pilot and feasibility study (GLIMPSE, NCT02690168), which identified a novel biomarker, glial acetate metabolism, that appears to predict the susceptibility to hypoglycemia. By providing an assay to predict hypoglycemic events and therefore diabetic complications, the development of this biomarker could significantly improve the... Read More
Gender:
All
Ages:
Between 18 years and 40 years
Trial Updated:
08/22/2023
Locations: Pennington Biomedical Research Center, Baton Rouge, Louisiana
Conditions: Diabetes, Hypoglycemia
Register for Updates
Circulating Biomarkers in the Development of Type 1 Diabetes
NCT05505669
Recruiting
More than 100 million U.S. adults are now living with diabetes or prediabetes. Investigators still do not fully understand how diabetes develops and how the disease worsens. Insulin is a hormone that helps the body use sugar as a fuel and control blood-sugar levels. People with diabetes have problems making insulin. This is because their insulin-producing beta cells -in the pancreas-are damaged or destroyed. A biomarker is a biological molecule (such as DNA, RNA (the genetic material of cells) o... Read More
Gender:
All
Ages:
All
Trial Updated:
08/20/2023
Locations: City of Hope Medical Center, Duarte, California
Conditions: Diabetes
Register for Updates
Personalized Responses to Dietary Composition Trial 3
NCT04735835
Recruiting
The PREDICT 3 study will build on previous research in over 2,000 individuals to further refine machine learning models that predict individual responses to foods, with the aim of advancing precision nutrition science and individualized dietary advice. The study incorporates both standardized and controlled dietary intervention, for the purpose of testing postprandial responses to specific mixed meals, in addition to a free-living period with a dietary record for measuring responses to a large v... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
07/28/2023
Locations: Zoe US Inc., Needham, Massachusetts +1 locations
Conditions: Diabetes, Heart Diseases, Diet Habit, Diet Modification, Healthy, Obesity, Metabolism, Microbial Colonization
Register for Updates
Dementia and Diabetes Prevention Program
NCT04141878
Recruiting
This is a multicenter, randomized 2-arm clinical trial of two lifestyle interventions varying in intensity and format, in 400 older African American and non-Hispanic whites at increased risk of cognitive decline and dementia in the East San Francisco Bay Area. The trial will include two lifestyle interventions that differ in intensity and format: Aerobic Exercise (AEx) Intervention that involves aerobic activities with in-class walking workouts and tutorials and carried out at the East Oakland... Read More
Gender:
All
Ages:
60 years and above
Trial Updated:
05/10/2023
Locations: University of California, Davis Alzheimer's Disease Center, Walnut Creek, California
Conditions: Diabetes, Dementia
Register for Updates
The T1D Exchange Registry
NCT04629586
Recruiting
The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes. To participate, you will be asked to: Read and sign an online informed consent form Take a survey describing specific demog... Read More
Gender:
All
Ages:
All
Trial Updated:
05/04/2023
Locations: T1D Exchange, Boston, Massachusetts
Conditions: Diabetes Mellitus, Type 1, Diabetes, Type 1 Diabetes, Diabetes Mellitus
Register for Updates
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans With Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial
NCT04259047
Recruiting
This double-masked, 2-year, single-site, phase II RCT will test the efficacy of DREAM (Diabetes Regulation for Eye Sight and Memory to prevent cognitive decline in African Americans (AAs) with amnestic multiple domain mild cognitive impairment (MCI) and poorly controlled diabetes (i.e., hemoglobin A1c [HbA1c] level ≥ 7.5%). Participants will be randomized to DREAM [11 home-based treatment sessions with a community health worker (CHW), and 4 telehealth visits with a Diabetes Nurse Educator over 2... Read More
Gender:
All
Ages:
65 years and above
Trial Updated:
04/11/2023
Locations: Thomas Jefferson University, Philadelphia, Pennsylvania
Conditions: Mild Cognitive Impairment, Diabetes
Register for Updates
C-myc Biomarker Study for Diabetic Foot Ulcers
NCT04591691
Recruiting
This is a multi-center observational cohort study of patients with diabetic foot ulcers (DFU) to develop and validate potential tissue-based biomarkers that predict complete wound healing. Eligible and consented participants will begin standard of care treatment after collection of tissue specimens from the wound's edge. An additional tissue specimen is collected at 4 weeks if clinically indicated. Tissues will be tested for c-myc and phosphorylated glucocorticoid receptor (p-GR) levels using va... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/29/2023
Locations: University of California - San Francisco, San Francisco, California +5 locations
Conditions: Diabetes, Diabetic Foot, Diabetic Foot Ulcer, Diabetic Wound
Register for Updates